Atos Medical - US’ Post

Read the penultimate instalment of our new Medical Innovators interview with Dr Lana Bijelic, chief of the Peritoneal Surface Malignancy Unit at Barcelona’s Moisès Broggi Hospital. PS You can now listen to the complete interview on our Spotify podcast, Combat Innovators – The Present and Future of Cancer (link in comments below) ⬇️ 𝐖𝐞’𝐯𝐞 𝐜𝐨𝐯𝐞𝐫𝐞𝐝 𝐪𝐮𝐢𝐭𝐞 𝐚 𝐛𝐫𝐨𝐚𝐝 𝐫𝐚𝐧𝐠𝐞, 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐯𝐞𝐫𝐲 𝐬𝐭𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐨 𝐭𝐡𝐞 𝐞𝐧𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞. 𝐖𝐞’𝐫𝐞 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐨𝐧 𝐚 𝐧𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐂𝐨𝐦𝐛𝐚𝐭 𝐌𝐞𝐝𝐢𝐜𝐚𝐥. 𝐖𝐞 𝐡𝐚𝐯𝐞 𝐚𝐧 𝐢𝐧𝐭𝐫𝐚𝐥𝐮𝐦𝐢𝐧𝐚𝐥 𝐬𝐲𝐬𝐭𝐞𝐦 𝐭𝐨 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐛𝐞𝐜𝐚𝐮𝐬𝐞 𝐢𝐟 𝐲𝐨𝐮’𝐫𝐞 𝐫𝐞𝐦𝐨𝐯𝐢𝐧𝐠 𝐚 𝐭𝐮𝐦𝐨𝐮𝐫 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐥𝐮𝐦𝐞𝐧, 𝐚𝐫𝐞 𝐲𝐨𝐮 𝐫𝐞𝐦𝐨𝐯𝐢𝐧𝐠 𝐢𝐭 100% 𝐨𝐫 𝐰𝐨𝐮𝐥𝐝 𝐢𝐭 𝐛𝐞𝐧𝐞𝐟𝐢𝐭 𝐟𝐫𝐨𝐦 𝐩𝐞𝐫𝐡𝐚𝐩𝐬 𝐬𝐨𝐦𝐞 𝐥𝐨𝐜𝐨-𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? 𝐓𝐡𝐞𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐲𝐧𝐚𝐞 𝐬𝐩𝐚𝐜𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐨𝐯𝐚𝐫𝐢𝐚𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐬𝐩𝐚𝐜𝐞, 𝐰𝐞’𝐫𝐞 𝐝𝐨𝐢𝐧𝐠 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬. 𝐖𝐞’𝐫𝐞 𝐚𝐥𝐬𝐨 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮𝐫 𝐟𝐫𝐢𝐞𝐧𝐝 𝐚𝐧𝐝 𝐦𝐞𝐧𝐭𝐨𝐫, 𝐃𝐫 𝐒𝐮𝐠𝐚𝐫𝐛𝐚𝐤𝐞𝐫 𝐨𝐧 𝐍𝐈𝐏𝐄𝐂. 𝐈𝐧 𝐨𝐮𝐫 𝐮𝐫𝐨𝐥𝐨𝐠𝐲 𝐰𝐨𝐫𝐥𝐝, 𝐰𝐡𝐞𝐫𝐞 𝐬𝐮𝐫𝐠𝐞𝐨𝐧𝐬 𝐠𝐢𝐯𝐞 10, 15 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬, 𝐝𝐨 𝐲𝐨𝐮 𝐭𝐡𝐢𝐧𝐤 𝐭𝐡𝐞𝐫𝐞’𝐬 𝐚𝐧 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞 𝐢𝐧 𝐝𝐨𝐢𝐧𝐠 𝐦𝐨𝐫𝐞 𝐢𝐧 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐜𝐡𝐞𝐦𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐩𝐨𝐢𝐧𝐭 𝐨𝐟 𝐯𝐢𝐞𝐰, 𝐨𝐫 𝐚𝐫𝐞 𝐰𝐞 𝐣𝐮𝐬𝐭 𝐛𝐮𝐬𝐲𝐢𝐧𝐠 𝐨𝐮𝐫𝐬𝐞𝐥𝐯𝐞𝐬 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐰𝐞 𝐭𝐚𝐤𝐞 𝐦𝐨𝐫𝐞 𝐨𝐟 𝐚 𝐰𝐚𝐭𝐜𝐡𝐟𝐮𝐥 𝐰𝐚𝐢𝐭𝐢𝐧𝐠 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡? Well, I think in terms of chemotherapy, repeating treatments has always been an integral part of how chemotherapy is used. So, I think the HIPEC being used only as a one-off is the exception. Part of it is the difficulties we had in terms of being able to deliver something like HIPEC. We associated it only with the moment of surgery. But from all the other standpoints, certainly repeated treatments would be a more logical way of applying chemotherapy, local, regional, just the same as systemic.   So, the smarter we get about how to apply multiple treatments in an acceptable way, I think that’s going to be the key for moving HIPEC from one treatment to multiple treatments. That logical way of thinking should increase the efficacy of HIPEC. So, I think it’s a very intriguing idea. We certainly know from other studies of normothermic chemotherapy that repeated intraperitoneal treatments work. We know that from multiple randomised trials in ovarian cancer. So that’s an interesting aspect that we should study more, for sure. #medicalinnovation #peritoneal #coloncancer #HIPEC #CombatMedical

The Mayo Clinic, founded in 1864, is one of the most prestigious healthcare institutions in the world. It has consistently been ranked number one in the United States for seven consecutive years by U.S. News & World Report's Best Hospitals Honor Roll. The Mayo Clinic serves over 1.3 million patients annually, offering comprehensive medical care across various specialties. Known for its integrated clinical practice, education, and research, the Mayo Clinic combines the expertise of top-tier physicians and cutting-edge technology to provide exceptional patient care. Its commitment to patient-centered care and medical innovation has made it a global leader in healthcare. Advanced Cancer Care at the United States. CONTACT US NOW!! . . . #oncology #cancer #oncologia #cancerawareness #breastcancer #cancersurvivor #health #chemotherapy #cancercare #cancertreatment #medicine #cancersucks #covid #oncologist #cancerresearch #cancerfighter #healthcare #cancersupport #doctor #surgery #chemo #hematology #cancerwarrior #urology #hospital #prostatecancer #breastcancerawareness #beatcancer #medicina #medical

Read the penultimate instalment of our new Medical Innovators interview with Dr Lana Bijelic, chief of the Peritoneal Surface Malignancy Unit at Barcelona’s Moisès Broggi Hospital. PS You can now listen to the complete interview on our Spotify podcast, Combat Innovators – The Present and Future of Cancer (link in comments below) 𝐖𝐞’𝐯𝐞 𝐜𝐨𝐯𝐞𝐫𝐞𝐝 𝐪𝐮𝐢𝐭𝐞 𝐚 𝐛𝐫𝐨𝐚𝐝 𝐫𝐚𝐧𝐠𝐞, 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐯𝐞𝐫𝐲 𝐬𝐭𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐨 𝐭𝐡𝐞 𝐞𝐧𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞. 𝐖𝐞’𝐫𝐞 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐨𝐧 𝐚 𝐧𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐂𝐨𝐦𝐛𝐚𝐭 𝐌𝐞𝐝𝐢𝐜𝐚𝐥. 𝐖𝐞 𝐡𝐚𝐯𝐞 𝐚𝐧 𝐢𝐧𝐭𝐫𝐚𝐥𝐮𝐦𝐢𝐧𝐚𝐥 𝐬𝐲𝐬𝐭𝐞𝐦 𝐭𝐨 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐛𝐞𝐜𝐚𝐮𝐬𝐞 𝐢𝐟 𝐲𝐨𝐮’𝐫𝐞 𝐫𝐞𝐦𝐨𝐯𝐢𝐧𝐠 𝐚 𝐭𝐮𝐦𝐨𝐮𝐫 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐥𝐮𝐦𝐞𝐧, 𝐚𝐫𝐞 𝐲𝐨𝐮 𝐫𝐞𝐦𝐨𝐯𝐢𝐧𝐠 𝐢𝐭 100% 𝐨𝐫 𝐰𝐨𝐮𝐥𝐝 𝐢𝐭 𝐛𝐞𝐧𝐞𝐟𝐢𝐭 𝐟𝐫𝐨𝐦 𝐩𝐞𝐫𝐡𝐚𝐩𝐬 𝐬𝐨𝐦𝐞 𝐥𝐨𝐜𝐨-𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? 𝐓𝐡𝐞𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐲𝐧𝐚𝐞 𝐬𝐩𝐚𝐜𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐨𝐯𝐚𝐫𝐢𝐚𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐬𝐩𝐚𝐜𝐞, 𝐰𝐞’𝐫𝐞 𝐝𝐨𝐢𝐧𝐠 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬. 𝐖𝐞’𝐫𝐞 𝐚𝐥𝐬𝐨 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮𝐫 𝐟𝐫𝐢𝐞𝐧𝐝 𝐚𝐧𝐝 𝐦𝐞𝐧𝐭𝐨𝐫, 𝐃𝐫 𝐒𝐮𝐠𝐚𝐫𝐛𝐚𝐤𝐞𝐫 𝐨𝐧 𝐍𝐈𝐏𝐄𝐂. 𝐈𝐧 𝐨𝐮𝐫 𝐮𝐫𝐨𝐥𝐨𝐠𝐲 𝐰𝐨𝐫𝐥𝐝, 𝐰𝐡𝐞𝐫𝐞 𝐬𝐮𝐫𝐠𝐞𝐨𝐧𝐬 𝐠𝐢𝐯𝐞 10, 15 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬, 𝐝𝐨 𝐲𝐨𝐮 𝐭𝐡𝐢𝐧𝐤 𝐭𝐡𝐞𝐫𝐞’𝐬 𝐚𝐧 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞 𝐢𝐧 𝐝𝐨𝐢𝐧𝐠 𝐦𝐨𝐫𝐞 𝐢𝐧 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐜𝐡𝐞𝐦𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐩𝐨𝐢𝐧𝐭 𝐨𝐟 𝐯𝐢𝐞𝐰, 𝐨𝐫 𝐚𝐫𝐞 𝐰𝐞 𝐣𝐮𝐬𝐭 𝐛𝐮𝐬𝐲𝐢𝐧𝐠 𝐨𝐮𝐫𝐬𝐞𝐥𝐯𝐞𝐬 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐰𝐞 𝐭𝐚𝐤𝐞 𝐦𝐨𝐫𝐞 𝐨𝐟 𝐚 𝐰𝐚𝐭𝐜𝐡𝐟𝐮𝐥 𝐰𝐚𝐢𝐭𝐢𝐧𝐠 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡? Well, I think in terms of chemotherapy, repeating treatments has always been an integral part of how chemotherapy is used. So, I think the HIPEC being used only as a one-off is the exception. Part of it is the difficulties we had in terms of being able to deliver something like HIPEC. We associated it only with the moment of surgery. But from all the other standpoints, certainly repeated treatments would be a more logical way of applying chemotherapy, local, regional, just the same as systemic. So, the smarter we get about how to apply multiple treatments in an acceptable way, I think that’s going to be the key for moving HIPEC from one treatment to multiple treatments. That logical way of thinking should increase the efficacy of HIPEC. So, I think it’s a very intriguing idea. We certainly know from other studies of normothermic chemotherapy that repeated intraperitoneal treatments work. We know that from multiple randomised trials in ovarian cancer. So that’s an interesting aspect that we should study more, for sure. #medicalinnovation #peritoneal #coloncancer #HIPEC #CombatMedical

June 8 is Brain Tumor Awareness Day. Early detection and timely treatment of brain tumors is crucial. Learning about a brain tumor can be daunting, but it's important to know that not all tumors are cancerous—about two-thirds are benign, though they can still impact brain function. At Cleveland Clinic, our healthcare team creates individualized treatment plans to address brain tumors and enhance quality of life. Brain tumor surgery is complex, requiring exceptional skill and experience. Our outcomes data highlights our expertise and commitment to patient safety and successful results(July 2023, ACS NSQIP Semi Annual Report) For patients in #India, we offer peer-to-peer video visits and second opinions to help navigate treatment options. Contact the IMAS Healthcare office in Hyderabad for access to Cleveland Clinic's second opinion services. 📧 Contact@imashealth.com 📞 +91 8008427271 Let's spread awareness and support those affected by brain tumors. #BrainTumorAwarenessDay #brainhealth #ClevelandClinic #Healthcare #PatientCare #brainsurgery #secondopinions #digitalhealth #telemedicine

Gynecologic Oncology focuses on the diagnosis and multidisciplinary treatment of cancers affecting the female reproductive system. This specialized field integrates various medical disciplines, such as surgery, radiation oncology, and medical oncology, to provide comprehensive and personalized care. Diagnosis often involves a combination of imaging studies, biopsies, and laboratory tests to determine the type and stage of cancer. Multidisciplinary treatment may include surgery to remove tumors, chemotherapy to target cancer cells, and radiation therapy to destroy or shrink tumors. Dr. Lakshmi Seshadri MBBS, MD (Consultant Obstetrician & Gynecologist) Contact: +91 7305006930 Website: https://lnkd.in/d3zufkdt Keywords: Healthcare Consultation, Medical Second Opinion, Telemedicine Services, Virtual Health Advisory, Expert Medical Advice, Healthcare Experts, Online Health Consultation, Medical Insights, Health Advisory Services, Telehealth Solutions, Healthcare Navigation, Patient Empowerment, Medical Advisory Services #GynecologicOncology #CancerDiagnosis #MultidisciplinaryTreatment #FemaleReproductiveSystem #OvarianCancer #UterineCancer #CervicalCancer #VulvarCancer #VaginalCancer #MedicalDisciplines #ComprehensiveCare #PersonalizedTreatment #Surgery #Chemotherapy #RadiationTherapy

Lower your risk by keeping your appointment ladies.

𝐓𝐲𝐩𝐞𝐬 𝐨𝐟 𝐁𝐫𝐚𝐢𝐧 𝐓𝐮𝐦𝐨𝐫𝐬: 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐚𝐧𝐝 𝐌𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐓𝐮𝐦𝐨𝐫𝐬 - 𝐔𝐧𝐢𝐬𝐜𝐚𝐧 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐁𝐫𝐚𝐢𝐧 𝐓𝐮𝐦𝐨𝐫𝐬 Primary brain tumors originate in the brain itself. They can be benign (non-cancerous) or malignant (cancerous). Examples include gliomas, meningiomas, and pituitary tumors. These tumors start in the brain and generally do not spread to other parts of the body. 𝐌𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐁𝐫𝐚𝐢𝐧 𝐓𝐮𝐦𝐨𝐫𝐬 Metastatic brain tumors are cancerous tumors that have spread to the brain from other parts of the body, such as the lungs, breasts, or skin (melanoma). These are more common than primary brain tumors and often indicate advanced cancer in the originating site. 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 Both primary and metastatic brain tumors are diagnosed through imaging techniques like MRI and CT scans, and sometimes require biopsy. Treatment options vary based on the type, size, and location of the tumor, and may include surgery, radiation therapy, chemotherapy, and targeted therapies. Best-in -Class Clinical laboratory Services 📞Call us at +91 875 402 8362 or visit our website https://uniscanlabs.com for more information. #fibroscan #liver #health #fattyliver #liverscan #edgarmora #vomiting #endoscopy #diabetes #highcholestarol #hepatits #alcoholicliver #nausea #swellingoverlegs #gastromedical #primehospitalpanipat #lossofappetite #diarrhea #fatigue #yellowskin #nafld #liverproblem #liverinflammation #hepatitsb #livertips #healtyliver #colonoscopia #endoscopia #free #liverhealth

Bone cancer is a serious and life-changing condition that affects people of all ages and genders. It's essential to be aware of the signs and symptoms to catch it early and seek medical assistance if needed. At Dharan Cancer Speciality Centre, we understand the impact that Bone Cancer can have on individuals and their loved ones. That's why we use advanced diagnostic techniques to identify Bone Cancer accurately. We utilize state-of-the-art imaging technologies, such as MRI and CT scans, to determine the size, location, and severity of the tumour accurately. Our multidisciplinary approach combines the expertise of various specialists, including Oncologists, Orthopaedic Surgeons, and Radiologists. We work together to deliver exceptional care and achieve the best possible outcomes for our patients. If you or a loved one is looking for compassionate care and expert treatment for Bone Cancer, look no further than Dharan Cancer Speciality Centre. Schedule your appointment today and Together, we can fight Bone cancer with Strength and Resilience. #bonecancer #bonecancerawareness #bonecancertreatment #cancerpatients #cancercare #cancercentre #cancertreatment #cancerhospital #salemcancerhospital #dharancancercare #besthospital #besttreatment #salem For Further Query #Call: +91 - 99439 39990 #Visit: https://lnkd.in/gY4mhra

The @SusanGKomen website in a recognized wealth of information for #breastcancer physicians, researchers, patients and caregivers. Susan G. Komen recognizes two emerging areas in the treatment of DCIS to be: 1) Predicting which cases of ductal carcinoma in situ (#DCIS) will progress to invasive breast cancer and 2) Determining which women may not need radiation therapy after lumpectomy for DCIS. #PreludeDx is excited to be included on the Susan G. Komen website and recognized for its #DCISionRT’s success in addressing these important questions. #DCISionRT is the only risk assessment test that provides a 10-year Total and Invasive Risk Score with breast conserving surgery alone (BCS) and BCS + radiation therapy (RT). DCISionRT is the only predictive assay for RT and identifies low-risk patients that may be able to omit RT, elevated-risk patients that may benefit from RT and high-risk patients that may need intensified therapy. To learn more https://lnkd.in/gPhnC9HJ. #bcsm

many important updates in this field are here